Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 pharmacokinetic study of oral fasudil in healthy volunteers (FAS1)
jRCTs041210145Phase 1Completed
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of fasudil (2 cohorts). Primary endpoint: Plasma concentration-time profile of M3 (active metabolite of fasudil). Started Nov 2022; status: completed.
02
Drugs
fasudil
Beyond the preview
Go deeper on jRCTs041210145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041210145.